Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,168 GBp
Change Today -16.00 / -1.35%
Volume 2.9M
SN/ On Other Exchanges
New York
As of 11:35 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

smith & nephew plc (SN/) Snapshot

1,182 GBp
Previous Close
1,184 GBp
Day High
1,186 GBp
Day Low
1,161 GBp
52 Week High
03/3/15 - 1,216 GBp
52 Week Low
10/16/14 - 881.00 GBp
Market Cap
Average Volume 10 Days
0.56 GBp
Shares Outstanding
0.33 GBp
Dividend Yield
Current Stock Chart for SMITH & NEPHEW PLC (SN/)

Related News

No related news articles were found.

smith & nephew plc (SN/) Related Businessweek News

No Related Businessweek News Found

smith & nephew plc (SN/) Details

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopedic reconstruction products, including hip and knee implants, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints. In addition, this segment offers arthroscopy enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue; and gynecological instrumentation devices. The company’s Advanced Wound Management segment offers a range of products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns, and post-operative wounds. This segment also provides traditional and single-use negative pressure wound therapy and hydrosurgery systems; and biologics and other bioactive technology products for debridement and dermal repair/regeneration. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

14,242 Employees
Last Reported Date: 03/5/15
Founded in 1856

smith & nephew plc (SN/) Top Compensated Officers

Chief Executive Officer, Director, Chairman o...
Total Annual Compensation: $3.2M
Chief Financial Officer, Director and Member ...
Total Annual Compensation: $1.8M
Compensation as of Fiscal Year 2014.

smith & nephew plc (SN/) Key Developments

Smith & Nephew plc Announces Final Dividend for the Year Ended 31 December 2014, Payable on 6 May 2015

Smith & Nephew plc announced a final dividend of 18.6 US cents per ordinary share in respect of the year ended 31 December 2014 will be paid on 6 May 2015 to shareholders whose names appeared on the register at the close of business on 17 April 2015. Those shareholders whose address on the Register is in the UK, and those who have validly elected to receive sterling dividends, will receive a dividend of 12.34 pence per share.

Smith & Nephew plc Appoints KPMG LLP as Auditor

Smith & Nephew plc appointed KPMG LLP as the Auditor at the Annual General Meeting held on 9 April 2015.

Smith & Nephew Announces the Launch of Q-FIX All-Suture Anchor

Smith & Nephew plc announced the launch of its Q-FIX All-Suture Anchor. Designed for procedures like rotator cuff repair and labrum repair in which anatomic space is very limited, the new anchor delivers performance characteristics that meet or exceed those of much larger, hard anchors. Unlike the performance of other all-suture anchors which can vary based on factors such as poor knot deployment or a surgeon's ability to fully tension the suture by hand, the Q-FIX implant uses a unique, radially expanding implant that fully deploys at the same depth within the bone every time. The Q-FIX anchor also uses an exclusive deployment dial located on the inserter's handle to automatically tighten the suture to a target of 140 Newtons - three times more than is possible using hand tensioning. Insufficient tensioning can result in micromotion caused by the suture's natural elasticity, which may reduce anchor performance. Indicated for use in the shoulder and hip, the Q-FIX anchor is available in both 1.8mm (single loaded) and 2.8mm (double loaded) sizes with associated disposable and reusable instruments.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SN/:LN 1,168.00 GBp -16.00

SN/ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr567.50 DKK +4.00
Edwards Lifesciences Corp $132.38 USD -5.95
Olympus Corp ¥4,505 JPY -5.00
St Jude Medical Inc $72.68 USD -0.79
Zimmer Holdings Inc $116.85 USD -1.91
View Industry Companies

Industry Analysis


Industry Average

Valuation SN/ Industry Range
Price/Earnings 32.3x
Price/Sales 3.5x
Price/Book 4.0x
Price/Cash Flow 32.2x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at